ConforMIS files for an initial public offering worth up to $173 million for its customized joint implant technology as it gears up for a new hip product this year.
ConforMIS today unveiled plans for an initial public offering worth up to $172.5 million, saying it plans to file for FDA approval of its customized hip implant this year.
Bedford, Mass.-based ConforMIS said it plans to trade on the NASDAQ exchange under the CFMS symbol. The company originally filed confidentially March 20, according to the SEC.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ekQ3Zs
Cap comentari:
Publica un comentari a l'entrada